Advertisement
U.S. Markets close in 4 hrs 46 mins

BioCryst Pharmaceuticals Inc (BO1.MU)

Munich - Munich Delayed Price. Currency in EUR
6.85-0.09 (-1.27%)
As of 08:00AM CEST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
382,236
331,412
270,827
157,170
17,812
Cost of Revenue
5,899
4,661
6,594
7,264
1,676
Gross Profit
376,337
326,751
264,233
149,906
16,136
Operating Expense
436,655
430,460
412,668
327,626
190,893
Operating Income
-60,318
-103,709
-148,435
-177,720
-174,757
Net Non Operating Interest Income Expense
-84,933
-92,462
-93,965
-59,232
-5,081
Other Income Expense
-1,246
-30,058
-1,983
55,143
-2,976
Pretax Income
-146,497
-226,229
-244,383
-181,809
-182,814
Tax Provision
-564
310
2,733
2,253
0
Net Income Common Stockholders
-145,933
-226,539
-247,116
-184,062
-182,814
Diluted NI Available to Com Stockholders
-145,933
-226,539
-247,116
-184,062
-182,814
Basic EPS
-0.94
-1.18
-1.33
-1.03
-1.09
Diluted EPS
-0.94
-1.18
-1.33
-1.03
-1.09
Basic Average Shares
115,600
192,198
185,908
179,117
167,267
Diluted Average Shares
115,600
192,198
185,908
179,117
167,267
Total Operating Income as Reported
-60,318
-103,709
-148,435
-177,720
-174,757
Total Expenses
442,554
435,121
419,262
334,890
192,569
Net Income from Continuing & Discontinued Operation
-145,933
-226,539
-247,116
-184,062
-182,814
Normalized Income
-144,692
-202,793
-245,549
-224,316
-179,838
Interest Income
16,234
15,777
5,127
62
9,420
Interest Expense
101,167
108,239
99,092
59,294
14,501
Net Interest Income
-84,933
-92,462
-93,965
-59,232
-5,081
EBIT
-45,330
-117,990
-145,291
-122,515
-168,313
EBITDA
-43,861
-116,335
-143,854
-121,738
-167,565
Reconciled Cost of Revenue
5,899
4,661
6,594
7,264
1,676
Reconciled Depreciation
1,469
1,655
1,437
777
748
Net Income from Continuing Operation Net Minority Interest
-145,933
-226,539
-247,116
-184,062
-182,814
Total Unusual Items Excluding Goodwill
-1,246
-30,058
-1,983
55,143
-2,976
Total Unusual Items
-1,246
-30,058
-1,983
55,143
-2,976
Normalized EBITDA
-42,615
-86,277
-141,871
-176,881
-164,589
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-4.797
-6,312
-416.43
14,889
0